| Solara Active Pharma Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541540 |
NSE Symbol : SOLARA |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE624Z01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.01 |
|
Book Value(₹) : 345.21 |
Market Cap(₹Cr) : 2,430.40 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,283.76 | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 |
| Other Income | 9.14 | 5.37 | 22.14 | 18.76 | 28.41 |
| Stock Adjustments | -39.00 | -39.27 | -7.05 | 258.75 | 2.15 |
| Total Income | 1,253.90 | 1,255.02 | 1,458.90 | 1,545.85 | 1,647.44 |
| EXPENDITURE : | |||||
| Raw Materials | 587.41 | 765.75 | 781.78 | 912.64 | 726.56 |
| Power and Fuel Cost | 94.37 | 122.56 | 107.95 | 93.70 | 85.42 |
| Other Manufacturing Expenses | 67.80 | 109.31 | 90.76 | 97.87 | 91.19 |
| Selling and Administration Expenses | 58.68 | 70.40 | 67.50 | 76.39 | 76.07 |
| Miscellaneous Expenses | 20.98 | 222.41 | 26.68 | 35.43 | 26.83 |
| Employee Benefit Expenses | 214.75 | 246.57 | 228.05 | 234.20 | 227.63 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 212.98 | -279.33 | 156.18 | 95.62 | 413.74 |
| Interest | 114.81 | 105.97 | 90.06 | 75.27 | 84.47 |
| Gross Profit | 98.17 | -385.30 | 66.12 | 20.35 | 329.27 |
| Depreciation | 99.25 | 103.03 | 110.90 | 112.01 | 108.31 |
| Profit Before Tax | -1.08 | -488.33 | -44.78 | -91.66 | 220.96 |
| Current Tax | 0.00 | 0.00 | -0.11 | 0.00 | 38.64 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 78.54 | -22.46 | -33.10 | -38.64 |
| Reported Net Profit | -1.08 | -566.87 | -22.21 | -58.56 | 220.96 |
| Extraordinary Items | 0.00 | -158.84 | -0.45 | -4.26 | 1.65 |
| Adjusted Net Profit | -1.08 | -408.03 | -21.76 | -54.30 | 219.31 |
| Adjustment below Net Profit | 1.06 | 0.56 | -1.76 | 2.01 | -2.53 |
| Profit/Loss Balance carried down | -316.27 | 250.04 | 274.01 | 341.34 | 142.65 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 10.78 | 19.74 |
| P & L Balance carried down | -316.29 | -316.27 | 250.04 | 274.01 | 341.34 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 30.00 | 0.00 | 70.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 |
| Earnings Per Share-Unit Curr | -0.27 | -157.46 | -6.17 | -16.27 | 61.50 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 272.35 | 260.39 | 417.54 | 424.18 | 443.30 |
| Book Value(Adj)-Unit Curr | 272.35 | 239.98 | 384.83 | 390.94 | 408.56 |